Recent Finacing
Recent Raise
Cerulean Pharma develops nanopharmaceuticals with a proprietary nanoparticle platform to deliver small molecules, peptides, and RNA, advancing CRLX101 in Phase 2 NSCLC and a docetaxel candidate toward trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
